FDA Approved: ZALTRAP — Original Application (sanofi-aventis U.S. LLC)

View source ↗

Summary

FDA original approval of ZALTRAP (ziv-aflibercept) from Sanofi-U.S. LLC for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Zaltrap (ramucirumab)

Snippet

ORIG AP for ZALTRAP (ZIV-AFLIBERCEPT)